1. Home
  2. CLDX vs AMPH Comparison

CLDX vs AMPH Comparison

Compare CLDX & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • AMPH
  • Stock Information
  • Founded
  • CLDX N/A
  • AMPH 1996
  • Country
  • CLDX United States
  • AMPH United States
  • Employees
  • CLDX N/A
  • AMPH N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLDX Health Care
  • AMPH Health Care
  • Exchange
  • CLDX Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • CLDX 1.3B
  • AMPH 1.1B
  • IPO Year
  • CLDX 2008
  • AMPH 2014
  • Fundamental
  • Price
  • CLDX $20.66
  • AMPH $23.81
  • Analyst Decision
  • CLDX Buy
  • AMPH Hold
  • Analyst Count
  • CLDX 9
  • AMPH 5
  • Target Price
  • CLDX $50.00
  • AMPH $36.25
  • AVG Volume (30 Days)
  • CLDX 843.8K
  • AMPH 489.0K
  • Earning Date
  • CLDX 08-07-2025
  • AMPH 08-07-2025
  • Dividend Yield
  • CLDX N/A
  • AMPH N/A
  • EPS Growth
  • CLDX N/A
  • AMPH N/A
  • EPS
  • CLDX N/A
  • AMPH 2.68
  • Revenue
  • CLDX $5,790,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • CLDX N/A
  • AMPH $0.92
  • Revenue Next Year
  • CLDX N/A
  • AMPH $5.55
  • P/E Ratio
  • CLDX N/A
  • AMPH $8.89
  • Revenue Growth
  • CLDX N/A
  • AMPH 1.37
  • 52 Week Low
  • CLDX $14.40
  • AMPH $20.39
  • 52 Week High
  • CLDX $47.00
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 40.75
  • AMPH 61.54
  • Support Level
  • CLDX $20.65
  • AMPH $20.70
  • Resistance Level
  • CLDX $22.60
  • AMPH $22.90
  • Average True Range (ATR)
  • CLDX 1.11
  • AMPH 0.81
  • MACD
  • CLDX -0.28
  • AMPH 0.23
  • Stochastic Oscillator
  • CLDX 10.64
  • AMPH 79.35

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: